“…To evaluate its role in gastric carcinogenesis, some studies discriminated between metaplasias that are adjacent to GC and those not coexisting with GC in evaluating legions for MSI (Semba et al, 1996;Hamamoto et al, 1997;Leung et al, 2000;Lee et al, 2002;. Previous results of MSI in gastric precancerous legions according to the markers and samples were summarized in Table 1 (Semba et al, 1996;Hamamoto et al, 1997;Endoh et al, 2000;Kashiwagi et al, 2000;Kim et al, 2000;Kobayashi et al, 2000;Leung et al, 2000;Jin et al, 2001;Kim et al, 2002;Lee et al, 2002;Garay et al, 2004;Liu et al, 2005;Zaky et al, 2008;Park et al, 2013). In gastric precancerous legions without GC, the frequency of MSI was low under 10% of cases except the studies by Semba et al (1996) (33.3%, 4/12) and Zaky et al (2008) (20.5%, 8/39).…”